Skip to main content
. 2018 Oct 19;78(10):927–948. doi: 10.1055/a-0646-4522
No. Recommendations/Statements EG LoE Sources
3.11. a) Mammography is the only method associated with a verified reduction in breast cancer mortality rates. ST 1a 1 ,  2 ,  3 ,  4 ,  5 ,  6 ,  7 ,  8 ,  9
b) It is recommended that women between the ages of 50 and 69 participate in the (German) national mammography screening program. Women aged 70 and above should be offered screening which takes account of their individual risk profile and health status as well as whether they have a life expectancy of more than 10 years. A/B 1a 1 ,  2 ,  7 ,  9 ,  10 ,  11 ,  12 ,  13
c) The reduction of breast cancer mortality has also been proven for women between the ages of 40 and 49 years and outweighs any risks arising from exposure to radiation. The reduction in mortality is, however, lower than that reported for women between the ages of 50 and 69 years and, in relative terms, there are more false-positive and false-negative findings in the younger group. The decision to have screening or not should therefore be based on an individual risk analysis, the weighing up of benefits and risk and should take the womanʼs preferences and objections into account. B 1b 1 ,  2 ,  8 ,  14
d) The quality of the structures, processes and results for curative mammography must be the equivalent of those described above. EC
e) If the mammography findings are category 0, III, IV or V (unclear or suspicious findings), additional workup procedures should be carried out within one week to minimize the psychological stress for the affected woman. EC